Clinical Trial Update: ToleroMune House Dust Mite Follow on Study

View source ↗

Summary

ToleroMune was studied in a follow-on trial for house dust mite allergy and rhinoconjunctivitis; the study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• House Dust Mite Allergy

Drugs mentioned

• ToleroMune

Snippet

Sponsor: Circassia Limited | Conditions: House Dust Mite Allergy, Rhinoconjunctivitis | Status: COMPLETED